Table 1.
Therapies targeting the metastatic cascade
Drug name | Target | Drug type |
---|---|---|
Angiogenesis | ||
Bevacizumab | VEGF | mAb |
Ziv-Aflibercept | VEGFA, VEGFB | fusion protein |
Ramucirumab | VEGF-R2 | mAb |
Sorafenib | VEGF-R | small molecule |
Pazopanib | VEGF-R | small molecule |
Lenvatinib | VEGF-R | small molecule |
Tivozanib | VEGF-R | small molecule |
Ponatinib | VEGF-R | small molecule |
Sunitinib | VEGF-R | small molecule |
Regorafenib | VEGF-R | small molecule |
Vandetanib | VEGF-R | small molecule |
Epithelial mesenchymal transition | ||
Cetuximab | EGFR | mAb |
Erlotinib | EGFR | small molecule |
Panitumumab | EGFR | mAb |
NP137 | Netrin | mAb |
Pritumumab | Vimentin | mAb |
Migration and invasion | ||
AT13148 | Rho | small molecule |
Fasudil | Rho kinase | small molecule |
Ketorolac | Rac1 | small molecule |
Ulixertinib | ERK1/2 | small molecule |
Trametinib | MEK | small molecule |
Cobimetinib | MEK | small molecule |
Binimetinib | MEK | small molecule |
Intravasation | ||
Rebastinib | TIE2 | small molecule |
PLX7486 | CSF1R | small molecule |
ARRY-382 | CSF1R | small molecule |
RG7155 | CSF1R | mAb |
FPA008 | CSF1R | mAb |
Pexidartinib | CSF1R | small molecule |
Immune invasion | ||
Lirilumab | NK cell receptor | mAb |
Monalizumab | NK cell receptor | mAb |
AZD5069 | CXCR2 | small molecule |
Pulmozyme | NET | DNase |
Disulfiram | aldehyde dehydrogenase | small molecule |
Pembrolizumab | PD1 | mAb |
Sintilimab | PD1 | mAb |
Nivolumab | PD1 | mAb |
Toripalimab | PD1 | mAb |
Atezolizumab | PD-L1 | mAb |
Durvalumab | PD-L1 | mAb |
Avelumab | PD-L1 | mAb |
Ipilimumab | CTLA4 | mAb |
Tremelimumab | CTLA4 | mAb |
Colonization | ||
Fresolimumab | TGF-β | mAb |
Trabedersen | TGF-β | antisense oligonucleotide |
Vigil | TGF-β | vaccine |
Plerixafor | CXCR4 | small molecule |
Denosumab | RANKL | mAb |
Zoledronic acid | osteoclasts | bisphosphonate |
Clodronate | osteoclasts | bisphosphonate |
Pamidronate | osteoclasts | bisphosphonate |
Uproleselan | E-selectin | small molecule |
Prosaposin | Thrombospondin 1 | short peptide |
Abemaciclib | CDK4/6 | small molecule |
Anoikis resistance | ||
Defactinib | FAK | small molecule |
Ifebemtinib | FAK | small molecule |
PND-1186 | FAK | small molecule |
GSK2256098 | FAK | small molecule |
Etaracizumab | αvβ3 | mAb |
Cilengitide | integrins | small molecule |
Conteltinib | integrins | small molecule |
Extravasation | ||
Heparin | P-selectin | polysaccharide |
Eptifibatide | αIIbβ3 | small molecule |
Tirofiban | αIIbβ3 | small molecule |
Abciximab | αIIbβ3 | mAb |
Data are correct as of October 19, 2024; searches done by Ian Miranda.